Breakthrough Stem Cell Dog Chews Show Promising Results in Veterinary Trials
Bioadaptives Inc's PawPa division has developed Regen Dog Chews that demonstrate significant potential for improving canine health through natural stem cell stimulation, with clinical trials showing a dramatic increase in circulating stem cells.
Bioadaptives Inc has unveiled compelling clinical results for its Regen Dog Chews, a novel pet wellness product designed to naturally enhance canine vitality and mobility. Veterinarian-led trials revealed a remarkable 281.3% increase in circulating stem cells after just four weeks of use, suggesting significant potential for improving dog health.
The product, developed by PawPa, Bioadaptives' premium pet wellness division, utilizes an innovative approach to canine supplementation. Crafted with all-natural ingredients including beneficial cyanobacteria and adaptogens, Regen offers a science-backed solution for pet owners seeking to support their dogs' overall wellness.
A key feature of the product is its proprietary APBAR rating system, modeled after the human APGAR score. This assessment tool allows pet owners to track improvements in their dog's appearance, performance, behavior, attitude, and responsiveness, providing a comprehensive method of evaluating the supplement's effectiveness.
The clinical trials demonstrated not only the significant stem cell increase but also highlighted the product's safety profile. No adverse effects were reported during testing, positioning Regen as a potentially groundbreaking daily supplement for dog health maintenance.
For veterinarians and pet owners increasingly interested in natural wellness approaches, Regen represents a promising development in canine nutritional science. The product's ability to potentially enhance stem cell activity could have broader implications for addressing age-related mobility issues and supporting overall canine health.